Viracta Therapeutics, Inc. (VIRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0229
-0.0023 (-9.13%)
Mar 28, 2025, 2:51 PM EST
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $993.61 thousand as of March 31, 2025. Its market cap has decreased by -97.34% in one year.
Market Cap
993.61K
Enterprise Value
-3.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from 8.68M to 993.61K, a decrease of -88.56%. That is a compound annual growth rate of -41.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 993.61K | -84.46% |
| Dec 31, 2024 | 6.39M | -70.95% |
| Dec 29, 2023 | 22.02M | -60.52% |
| Dec 30, 2022 | 55.77M | -59.05% |
| Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.82B |
| SS Innovations International | 1.76B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 720.71M |
| Elite Pharmaceuticals | 470.04M |
| Glass House Brands | 371.89M |
| Northwest Biotherapeutics | 318.00M |
| CytoDyn | 288.56M |